Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Laryngol Otol ; 128(1): 43-8, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24451682

RESUMO

OBJECTIVE: To investigate the effectiveness of pomegranate extract as protection against aminoglycoside ototoxicity. DESIGN: Prospective, randomised, controlled, experimental study. SUBJECTS: Eighteen Wistar albino rats were randomly allocated to 5 days of either: saline injections; gentamicin injections; or pomegranate extract (100 µl/day via gavage) plus gentamicin injections. Distortion product otoacoustic emissions were tested before treatment and on day 3. After treatment, reactive oxygen species levels were measured in each rat's right cochlea and right kidney via chemiluminescence. RESULTS: Baseline emission amplitudes were similar. Post-treatment emissions differed significantly in the two treatment groups (p < 0.001). Cochlear reactive oxygen species levels were significantly higher in the gentamicin group (mean ± standard deviation, 316.6 ± 36.5 relative light units per mg) than the gentamicin plus pomegranate extract group (240 ± 24.6 relative light units per mg) (p = 0.004); control group levels were 119.1 ± 10.3 relative light units per mg. Renal reactive oxygen species levels were similar for the control and gentamicin plus pomegranate extract groups (p = 0.59) but much higher in the gentamicin group (p = 0.004). CONCLUSION: Concurrent systemic pomegranate extract administration reduced reactive oxygen species level increases and otoacoustic emission changes, following aminoglycoside injection.


Assuntos
Aminoglicosídeos/efeitos adversos , Antibacterianos/efeitos adversos , Cóclea/efeitos dos fármacos , Gentamicinas/efeitos adversos , Perda Auditiva Neurossensorial/prevenção & controle , Rim/efeitos dos fármacos , Lythraceae , Emissões Otoacústicas Espontâneas/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Antioxidantes/farmacologia , Cóclea/metabolismo , Feminino , Perda Auditiva Neurossensorial/induzido quimicamente , Rim/metabolismo , Medições Luminescentes , Estudos Prospectivos , Distribuição Aleatória , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo
2.
J Laryngol Otol ; 126(8): 784-8, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22804851

RESUMO

OBJECTIVE: To compare mucosal and bony measurements in patients with congenital and traumatic nasal septum deviation and compensatory inferior turbinate hypertrophy. METHODS: The study examined 50 patients with nasal septum deviation (25 congenital and 25 traumatic) and compensatory inferior turbinate hypertrophy in the contralateral nasal cavity, confirmed by computed tomography. RESULTS: The study compared inferior turbinate measurements on the concave and convex sides of the septum, in the congenital and traumatic groups. MEASUREMENTS COMPRISED: the shortest distance from the median line to the medial border of the conchal bone; the distances from the most medial part of the conchal mucosa and the conchal bone to the lateral line; the projection angle of the inferior turbinate; and the widest parts of the whole inferior turbinate and the inferior turbinate conchal bone. The differences between the concave and convex side measurements were compared in the congenital group versus the traumatic group; for three measurements, the difference between these two groups was statistically significant (p < 0.05). CONCLUSION: The present study findings suggest that the conchal bone has a marked influence on nasal patency in patients with congenital septal deviation. These findings supported the decision to excise the inferior turbinate bone at the time of septoplasty, especially when treating congenital septal deviation.


Assuntos
Cavidade Nasal/anatomia & histologia , Obstrução Nasal/etiologia , Septo Nasal/anormalidades , Deformidades Adquiridas Nasais/complicações , Conchas Nasais/patologia , Adolescente , Adulto , Feminino , Humanos , Hipertrofia/diagnóstico por imagem , Hipertrofia/etiologia , Masculino , Pessoa de Meia-Idade , Cavidade Nasal/diagnóstico por imagem , Cavidade Nasal/cirurgia , Obstrução Nasal/diagnóstico por imagem , Obstrução Nasal/cirurgia , Septo Nasal/diagnóstico por imagem , Septo Nasal/cirurgia , Deformidades Adquiridas Nasais/diagnóstico por imagem , Deformidades Adquiridas Nasais/cirurgia , Tomografia Computadorizada por Raios X , Conchas Nasais/diagnóstico por imagem , Conchas Nasais/cirurgia
3.
J Laryngol Otol ; 125(4): 370-5, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21349238

RESUMO

OBJECTIVE: To assess the effect of pomegranate extract on acute inflammation due to myringotomy. DESIGN: Prospective, randomised study. SUBJECTS: Thirty Sprague-Dawley rats were divided into three groups. Group one constituted controls. Group two underwent myringotomy. Group three underwent myringotomy and also received 100 µl/day pomegranate extract, via gavage, one day before and two days after surgery. Following sacrifice 48 hours after myringotomy, the animals' right ears were used to determine the concentration of reactive oxygen species, using the chemiluminescence method; left ears were used for histological study. RESULTS: Reactive oxygen species levels were significantly decreased in group three compared with group two (p < 0.01). The density of inflammatory cells in group three was significantly less than that in group two (p < 0.01). Lamina propria thickness and vessel density were also significantly decreased in group three compared with group two (p < 0.01). CONCLUSION: Our results indicate that oral pomegranate extract decreases reactive oxygen species concentration and acute inflammation in the tympanic membrane after myringotomy.


Assuntos
Antioxidantes/uso terapêutico , Lythraceae , Miringoplastia/efeitos adversos , Otite Externa/prevenção & controle , Fitoterapia/métodos , Administração Oral , Animais , Avaliação Pré-Clínica de Medicamentos/métodos , Luminescência , Otite Externa/etiologia , Otite Externa/patologia , Extratos Vegetais/uso terapêutico , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo , Membrana Timpânica/metabolismo , Membrana Timpânica/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA